CLINICAL_TRIALS
trial_result
· 2021-12-15
Clinical Trial Update: A Long-Term Safety Study of S5G4T-1 in the Treatment of Papulopustular Rosacea [Phase 3]
Summary
Phase 3 long-term safety study of S5G4T-1 in papulopustular rosacea was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sol-Gel Technologies, Ltd. | Conditions: Papulopustular Rosacea | Phase 3 | Status: TERMINATED | Results posted: 2021-12-15